Methods For Treating Cognitive Deficits Associated With Fragile X Syndrome


Provided herein are methods of treating a cognitive deficit, including cognitive deficits associated with a Fmr1 genetic defect. More particularly, provided herein are methods in which an effective amount of a MDM2-p53 pathway inhibitor is administered to a subject afflicted with at least one cognitive deficit, whereby administration of the inhibitor improves, enhances, or rescues at least one cognitive deficit in the subject.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2019
  • Application: Mar 8, 2018
    US US 201815915278 A
  • Priority: Mar 8, 2018
    US US 201815915278 A
  • Priority: Sep 23, 2016
    US US 201615274983 A
  • Priority: Sep 23, 2015
    US US 201562222267 P

Download Citation

Sign in to the Lens